. 2011 Feb 21;6:20. doi: 10.1186/1748-717X-6-20
Copyright ©2011 Wiezorek et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 2.
Dose at 99% of the PTV2 dependend on technology and TPS.